 |
|
|
|
Featured News
|
 |
Nelson Labs Celebrates Its 40th Anniversary
Nelson Labs, a global leader in testing and advisory services for the medical device and pharmaceutical industries, on May 5, recognized its 40th anniversary with a golf tournament and awards dinner at the Homestead in Midway, Utah. Founded in 1985 as a modest laboratory in the University of Utah’s Research Park, Nelson Labs has since grown into an expansive network of 12 locations across North America, Asia, and Europe.
A steady rain didn't dampen the occasion, which was marked by golf enthusiasts who braved the weather, and a crowd of dedicated employees and guests who enjoyed an evening filled with good food and inspiring remarks by Nelson leadership. BioUtah representatives, Denise Bell and Josel McCabe, and BioUtah Board member, Jay Muse, were on hand to help commemorate the occasion. |
|
| |
|
BioUtah News
|
 |
Federal Reserve Learns About Life Sciences in Utah
On Friday, May 2, members of the BioUtah Board of Directors, Erin Barry, David Bearss, Myles Greenberg, and Jay Muse, along with CEO Kelvyn Cullimore, met with Abby McLennan, VP and regional executive for the Federal Reserve Bank of San Francisco's Salt Lake City Branch. The purpose of the meeting was to allow the Federal Reserve to have greater insights into the status of the life sciences industry in Utah and how economic factors are affecting the industry. The meeting was part of a structured outreach program by the Federal Reserve. Thanks to the board members who attended and provided their insights. And thanks to Abby McLennan for her interest in our industry. |
|
|
|
|
Varex Imaging Presented Global Pacesetter Award at Crossroads of the World Summit
At the Crossroads of the World Summit held this week, Varex Imaging was presented the Global Pacesetter Award from Zions Bank. Sunny Sanyal, CEO and president of Varex accepted the award on behalf of the company. The award recognizes a company doing business in Utah demonstrating international success — a well-deserved recognition for Sunny and the Varex team! |
|
|
 |
Crossroads of the World Summit Presented by Zions Bank and World Trade Center Utah
On May 7-8, 2025, BioUtah member, Zions Bank, and World Trade Center Utah presented the annual Crossroads of the World Summit. This two-day event was split between the Zions Bancorporation Operations Center and the Grand America Hotel. Three former Secretaries of State presented live, including Condoleeza Rice, Anthony Blinken, and Mike Pompeo. A panel on Tariffs and Trade featured Kim Honeysett, chief legal officer for BioUtah member, Varex Imaging. Also featured on the program were Governor and Abbey Cox, Jonathan Freedman (World Trade Center Utah), Natalie Gochnour (Kem C. Gardner Policy Institute), Former Ambassador, Jeff Flake, and Paul Burdiss & Harris Simmons of Zions Bank.
Click below to see the full program.
View Full Program » |
|
|
In Memory of Ping Fong, Jr.
It is with heavy hearts that we announce the passing of Ping Fong. Ping was a life sciences executive in Utah for many decades. He was a pioneer in forging collaborations such as Utah Life Sciences Association, which was a predecessor to BioUtah. He was also General Manager of Bunnell, Inc., a medical device company founded in Utah. In recent years, Ping has lived in Arkansas, where he contributed to building the life sciences community there, including being part of Bio Arkansas. Our hearts and condolences go out to his wife, Lucy, and their family.
More » |
|
|
|
|
Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
BioUtah President and CEO, Kelvyn Cullimore, recently penned an op-ed published in the Deseret News on the need to fix the Inflation Reduction Act's (IRA) "pill penalty." The pill penalty refers to a provision in the IRA that allows Medicare to impose government drug price negotiations for small-molecule drugs (like pills and tablets) years sooner than for large-molecule drugs (biologics). Cullimore notes that there are times when government interventions create unanticipated negative consequences. Such is the case with this IRA policy.
More »
|
|
|
|
|
|
Ratio Therapeutics to Establish New Radiopharmaceutical Manufacturing Facility in West Valley
Ratio Therapeutics has entered into an agreement with the Medical Innovation Technology Management division of Wasatch Group to partner and construct a state-of-the-art radiopharmaceutical research and manufacturing facility in Salt Lake City, Utah, anticipated to be fully operational in the second half of 2027. Proximity to Nusano was a key factor in Ratio TX's decision to relocate to Utah.
More » |
|
|
|
|
Recursion's "Evening of Hope"
Recursion has released a video encapsulating the Utah Rare Disease Day "Evening of Hope" held on February 27. BioUtah president and CEO, Kelvyn Cullimore, spoke at the event, which spotlighted the spirit and experiences of Utah's rare and undiagnosed community.
More » |
|
|
|
|
|
|
RAPS Utah Announces 2025 Leadership Team
Big things are happening at the RAPS Utah Chapter, including changes and additions to the Chapter Advisory Board. RAPS would like to introduce you to the 2025 Utah Chapter Leadership Team:
- Christopher Phillips, MSHS, RAC, CMDA: Chair
- Ryan Hogan.: Chair Elect
- Darlene R. Hull, RAC - US: Secretary
- Connor Dahl: Membership Lead
- Kristen Petersen: Communication Lead
- Derek Lewis: Mentorship Lead
More » |
|
|
|
|
Sera Prognostics Appoints Lee Anderson as Chief Commercial Officer
Sera Prognostics has appointed Lee Anderson as chief commercial officer. Bringing more than 30 years of cross-functional leadership experience in sales, marketing, customer service, strategic accounts, and training, Mr. Anderson has a proven track record of driving business growth and enhancing sales strategies in the healthcare sector.
More » |
|
|
|
|
|
Nominations Now Open: 2025 Innovations in Regulatory Science & Policy Awards
Help the Reagan-Udall Foundation for the FDA recognize leaders, innovators, and advocates in Utah's life sciences industry. The Innovations in Regulatory Science & Policy Awards recognize extraordinary contributions that have advanced regulatory science and impacted public health. You are invited to nominate an individual, team, or organization through the online portal, email, or mail. Complete nomination instructions and forms are available by clicking the link below.
Deadline for nominations is June 6.
More » |
|
|
|
|
2025 Utah Business Fast 50 Registration
Utah Business is proud to present the annual FAST 50 event - companies that have been in business at least five years, selected based on revenue growth and total revenue. In addition, Utah Business also recognizes emerging companies that have not been in business for the required five years, but have shown exponential growth.
Submission deadline is May 15.
More »
Utah Business: Nominations for Most Influential Women Open
The 2025 Most Influential Women will be honored specifically for what they have done to build our state, including charitable work, generating economic opportunity for Utahns, influencing meaningful legislation and more.
Nomination deadline is June 4.
Submit Nomination »
Utah Business: Nominations for Innovation Awards Open
The program recognizes the state’s vibrant community of innovators — from startups to established companies — and their breakthrough creations. The awards program aims to build the state’s economy by acknowledging and rewarding the creative minds fueling innovation within it.
Deadline for submissions is July 9.
Submit Nomination » |
|
|
| |
|
Featured BioUtah Elite Bronze Member
|
|
|
Vertex Pharmaceuticals strikes at the core of serious diseases to change people’s lives. Bringing together the brightest minds, investing in science and taking smart risks, Vertex goes all in. For the lives the company has changed and for those who are still waiting, Vertex will never stop fighting until cures are discovered. Vertex has research and development sites and commercial offices around the world, all dedicated to bringing the next transformative treatments to people with serious diseases. Vertex is headquartered in Boston and London.
More »
|
|
|
| |
|
Featured Events
|
 |
BioUtah, Utah Tech Host Luncheon for Southern Utah Life Sciences Companies
May 22, 2025
11:30 AM - 1:00 PM MT
11:30 - 12:00 PM: Networking
12:00 - 1:00 PM: Lunch
College of Sciences, Engineering & Technology
225 S. University Ave.
St. George, UT 84770
Free to Attend
BioUtah and Utah Tech University’s College of Sciences, Engineering, and Technology invite you to an exclusive luncheon designed to build stronger connections between industry and academia, and to provide an industry networking opportunity. This event offers a unique opportunity for companies in the life sciences and biotech sectors to explore collaboration possibilities with the university and its talented pool of students and faculty, and to socialize with others in the life sciences industry in Southern Utah.
Register » |
 |
BioHive: Support Youth in STEM
May 22, 2025
4:00 - 6:00 PM MT
The Gateway
Rooftop Patio
Enjoy sunshine, tacos, drinks, and help K-12 STEM with BioHive! Assemble "Tinker Totes” for students. You'll meet Doug Jorgensen, Highland High School Biotechnology program leader for Salt Lake School District.
Register » |
 |
|
|
Conducting Clinical Trials in Australia: Lunch & Learn
June 5, 2025
11:30 AM - 1:00 PM MT
11:30 - 12:00 PM: Networking
12:00 - 1:00 PM: Presentation
Governor's Office of Economic Opportunity
60 E. South Temple, Ste. 300
Salt Lake City, UT
Free to Attend
Have you considered Australia for your clinical trials? This in-person event will provide you with valuable insights into the strategic advantages of running clinical trials in Australia. With a 30-minute presentation followed by a Q&A session and networking, the event focuses on:
- Speed: Accelerated startup timelines and streamlined regulatory pathways.
- Cost: Competitive pricing and government incentives.
- Quality: High standards in data integrity, compliance, and patient care.
Register » |
|
|
 |
|
BIO International Convention: Advance Rates End May 23 — Register Now, Exhibitor Passes Available
JUNE 16-19, 2025
Boston Convention & Exhibition Center
Boston, MA
Time is running out! Register for BIO 2025 to lock in the advance rate and save on your ticket to Boston. If you plan to attend, please visit the Utah Pavilion at booth number 768. BioUtah has a limited supply of complimentary exhibitor passes for the exhibitor floor. Contact Kelvyn@bioutah.org if you are interested in obtaining a floor pass.
Register » |
| |
|
Podcasts
|
|
|
Vital Health Podcast: VT’s Grumpies talk IRA with Virginia Acha
In this special Grumpies episode, host Duane Schulthess, CEO of Vital Transformation, is joined by neuroscientist and US Business Director Joe Hammang, consulting economist Dr. Harry Bowen, and MSD Associate VP of Science and Regulatory Policy Virginia “Ginny” Acha. They examine the IRA and question its promise to lower drug prices for Medicare beneficiaries, revealing how it discourages R&D, reroutes venture capital, and restricts patient access.
Listen In » |
|
|
| |
|
Featured BioUtah Member Deal
|
|
Clean Harbors manages waste recycling and disposal for almost all waste streams, planned environmental and industrial services, as well as Emergency Response Services.
More »
|
|
|
| |
|
Earnings
|
|
|
Teva Reports Ninth Consecutive Quarter of Growth
Teva has recently reported the company's first quarter results.
Highlights include:
- Revenues of $3.9B, up 2%.
- Net Income of $220M compared to a loss of $419M in the prior year.
- Non-GAAP diluted EPS of $0.52, an increase of $0.04 or 8% year-over-year.
More » |
|
|
|
|
Denali Therapeutics Reports First Quarter 2025 Financial Results
Denali Therapeutics reported financial results for the first quarter ended March 31, 2025, and provided business highlights, including the Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome.
Other highlights include:
- Net loss of $133M compared to a net loss of $101.8M last year.
- R&D Expenses of $116.2M compared to $107M last year.
- Cash and Cash Equivalents on hand of $1.05B.
During the quarter, Denali opened its clinical biomanufacturing facility in Salt Lake City.
More » |
|
|
|
|
Myriad Genetics Reports First Quarter 2025 Financial Results
Myriad Genetics announced financial results for its first quarter ended March 31, 2025, and updated its previously issued financial guidance on business performance for the full year 2025.
Highlights include:
- Revenue of $196M declined by 3% year-over-year.
- Net Loss for the quarter was $100K due to a one-time tax benefit of $29M.
- Cash and Cash Equivalents of $92M.
More » |
|
|
|
|
|
Owlet Announces First Quarter 2025 Financial Results
Owlet reported financial results for the first quarter ended March 31, 2025.
Highlights include:
- Q1 Revenue of $21.1M, up 43.1% from Q1 2024.
- Q1 Net Income of $3.0M, compared to $3.3M in Q1 2024.
- Q1 Cash and Cash Equivalents of $17M.
More » |
|
|
|
|
Co-Diagnostics Reports First Quarter 2025 Financial Results
Co-Diagnostics announced financial results for the quarter ended March 31, 2025.
Highlights include:
- Revenue of $0.1M, which declined from $0.5M during Q1 2024.
- Cash & Cash Equivalents on hand of $21.5M.
- Operating loss of $8.6M compared to operating loss of $10.3M in Q1 2024.
More » |
|
|
| |
|
Policy Updates
|
|
|
BIO, CSBA Section 232 Investigation Comments
The Department of Commerce recently announced a Section 232 investigation into pharmaceuticals and related products. This investigation is significant as it could lead to a recommendation that the President impose substantial tariffs on pharmaceutical imports. BIO has submitted public comments to the Department of Commerce. The Council of State Bioscience Associations (CSBA) Board leaders also submitted a formal letter on behalf of the CSBA membership endorsing BIO’s submission.
More » |
|
|
|
|
Trump Expected to Sign 'Most Favored Nation' EO to Cut Drug Prices
As of this writing, reports have surfaced suggesting that President Trump intends to sign an executive order next week that would apply most favored nation (MFN) pricing to drugs in the Medicare and/or Medicaid program. Such a pricing system would link the prices of drugs in these programs to the lowest prices in foreign countries. While details are still outstanding, BioUtah and its national partners, BIO and PhRMA, are expressing concerns to lawmakers.
"Importing price controls from other nations with socialized medicine programs will limit access to treatment options for America’s most vulnerable patients and hinder important research and development," said Kelvyn Cullimore, president and CEO of BioUtah.
More » |
|
|
|
|
BioUtah Signs Letter on MFN Drug Pricing
BioUtah this week signed onto a letter to Congress, along with 40 other state bio associations, expressing concern about a “Most Favored Nation” (MFN) drug pricing proposal that could be considered as part of the Budget Reconciliation debate. MFN would impose in the U.S. drug price controls from other countries, threatening investment in new cures and putting America’s biotechnology leadership at risk.
View Letter » |
|
|
|
|
|
BioUtah Legislative Policy Call
BioUtah held its monthly policy call on April 24 reviewing activity of the Utah state legislature as well as policy developments at the federal level.
To view the agenda from the April 24 call, click here.
To sign up for future calls in 2025, click here.
|
|
|
|
| |
|
BioUtah Events
|
 |
Utah Association of Colleges & Employers (UACE) New Grad & Alumni Statewide Career Fair
May 14, 2025
3:00 - 6:00 PM MT
Veteran/Employer Networking: 2:30 - 3:00 PM MT
University of Utah
A. Ray Olpin Student Union Building
200 S Central Campus Dr.
Salt Lake City, UT
This exciting event attracts Utah alumni to connect with employers on one engaging day. Each of the member schools invites recent and experienced alumni to attend and engage with employers interested in acquiring new talent.
More » |
 |
Wilson Sonsini New SLC Office Open House
May 15, 2025
4:00 - 7:00 PM MT
Wilson Sonsini
95 S. State St.
Salt Lake City, UT
Please join the Wilson Sonsini Salt Lake City attorneys as they commemorate the company's move to a new office after three successful, growth-filled years as an integral member of the local business and legal community.
More » |
 |
Mayer Brown: IP in the Age of AI: Licensing and Enforcement Perspectives
May 20, 2025
12:00 PM MT | Lunch
12:30 - 1:30 PM MT | Presentation
Mayer Brown
201 S. Main Street, STE. 1100
Salt Lake City, UT
Modern technologies have altered the technical building blocks of intellectual property, demanding new strategies for IP protection, licensing, and enforcement. Join Mayer Brown to explore in depth how these trending issues impact innovation-focused emerging companies—and those who invest in them.
Register » |
 |
U Startup Launchpad
May 21, 2025
9:30 AM - 6:30 PM
Utah Museum of Fine Arts
410 Campus Center Dr.
Salt Lake City, UT
Ready to turn your innovation into a venture? Join successful founders, investors, and startup experts for a day of hands-on workshops and valuable networking.
More » |
 |
Utah APEX Accelerator Virtual Workshop: Beyond SBIRs: NIH as Your Partner
May 22, 2025
10:30 AM - 12:00 PM MT
The Utah APEX Accelerator office, in partnership with NIH, is hosting a virtual workshop featuring Dr. Michael Salgaller. This workshop will teach attendees how companies can partner with NIH to strengthen their pipelines or solve development challenges.
Register » |
| |
|
Industry Events
|
 |
MedTech Conference 2025
October 5-8, 2025
San Diego, CA
The Medical Device industry will gather in San Diego in October. Registration for MedTech 2025 is now open. Featuring world-class speakers, a cross-cutting educational program, invaluable networking and next-level technology, this forum for transformational ideas is a can’t-miss event for the industry’s prominent and most promising companies.
Register »
Apply Now to Showcase Your Innovations at MedTech 2025
Apply for one of these exclusive opportunities to put your company and technologies in front of future partners the broader medtech community.
Company Presentations: Take the Stage: Startups, small companies, and commercial-stage companies can spotlight their cutting-edge technologies during 9-minute Company Presentations to potential partners and investors.
Learn More and Apply »
Innovation Pavilion: Turnkey Kiosk: Exhibiting in the Innovation Pavilion offers unmatched visibility to showcase your groundbreaking medtech solutions to global industry leaders.
Join the Pavilion » |
| |
|
Funding Opportunities
|
|
|
Discuss Your SBIR/STTR Funding Needs with a Program Director
Are you seeking SBIR/STTR funding to help commercialize your cancer technology? Before you apply, we encourage you to schedule a one-on-one conversation with an NCI SBIR program director to:
- Get questions answered about SBIR/STTR funding and resources.
- Learn which opportunities can support your small business.
- Receive guidance on approaching the application process.
To get connected with a program director, email ncisbir@mail.nih.gov with an abstract, specific aims, or a quad chart describing your cancer technology.
More » |
|
|
|
|
Apply Now for SBIR/STTR Commercialization Funding
The Utah Innovation Center is accepting applications for the SBIR/STTR Commercialization Scholarship. This funding supports experienced SBIR/STTR companies in expanding customer discovery, connecting with industry partners, and attending key events, including those where you can meet directly with agency representatives. Tranche two of this funding is now open.
Review rules and apply for funding here » |
|
|
|
|
| |
|
International Trade
|
|
|
|
|
| |
|
A Special Thanks To BioUtah's Elite Members:
|
|
Legacy
|
 |
|
|
|
Platinum
|
 |
|
|
|
Gold
|
 |
|
|
|
Silver
|
 |
|
|
|
Bronze
|
 |
 |
230 E. South Temple, Suite #100
Salt Lake City, UT 84111 |
|
|
|
|
|